These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1910055)

  • 1. Primary anetoderma associated with a wide spectrum of autoimmune abnormalities.
    Hodak E; Shamai-Lubovitz O; David M; Hazaz B; Lahav M; Sandbank M
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 2):415-8. PubMed ID: 1910055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic abnormalities associated with primary anetoderma.
    Hodak E; Shamai-Lubovitz O; David M; Hazaz B; Katzenelson-Weissman V; Lahav M; Sandbank M
    Arch Dermatol; 1992 Jun; 128(6):799-803. PubMed ID: 1599266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus anticoagulant, anticardiolipin antibody or antiphospholipid syndrome?
    Malaviya AN
    J Assoc Physicians India; 1991 Mar; 39(3):239-41. PubMed ID: 1908856
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antiphospholipid antibody syndrome: its pathogenesis and clinico-morphological manifestations].
    Zerbino DD; Lukasevich LL; Bilynskaia OA
    Arkh Patol; 1990; 52(4):65-9. PubMed ID: 2117434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies and anetoderma: are they associated?
    Stephansson EA; Niemi KM
    Dermatology; 1995; 191(3):204-9. PubMed ID: 8534938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anetoderma and its prothrombotic abnormalities.
    Sparsa A; Piette JC; Wechsler B; Amoura Z; Francès C
    J Am Acad Dermatol; 2003 Dec; 49(6):1008-12. PubMed ID: 14639377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus anticoagulant. A report of 8 cases.
    Agarwal MB; Agarwal UM
    J Assoc Physicians India; 1991 Mar; 39(3):243-5. PubMed ID: 1908857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anetoderma in a systemic lupus erythematosus patient with anti-PCNA and antiphospholipid antibodies.
    Alvarez-Cuesta CC; Raya-Aguado C; Fernández-Rippe ML; Sánchez TS; Pérez-Oliva N
    Dermatology; 2001; 203(4):348-50. PubMed ID: 11752829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anetoderma during antiphospholipid syndrome. 3 cases].
    Disdier P; Christides C; Andrac-Meyer L; Rojat-Habib MC; Aillaud MF; Swiader L; Weiller-Merli C; Berbis P; Harlé JR; Weiller PJ
    Ann Dermatol Venereol; 1996; 123(12):800-3. PubMed ID: 9636765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibodies: an elderly statesman Dons new garments.
    Harris EN; Hughes GR; Gharavi AE
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():208-13. PubMed ID: 3112376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical manifestations associated with the presence of lupus anticoagulant].
    Miori L; Bellosta M; Miori E; Rabbiosi G
    G Ital Dermatol Venereol; 1989 Mar; 124(3):107-10. PubMed ID: 2509330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus erythematosus: an autoimmune disease of the nervous system?
    Burton RC; McDuffie FC; Mulder DW
    Res Publ Assoc Res Nerv Ment Dis; 1971; 49():197-214. PubMed ID: 4109092
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticardiolipin antibodies in acquired immunodeficiency syndrome.
    Stimmler MM; Quismorio FP; McGehee WG; Boylen T; Sharma OP
    Arch Intern Med; 1989 Aug; 149(8):1833-5. PubMed ID: 2504122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-phospholipid antibody with recurrent venous thromboembolism and severe autoimmune thrombocytopenia].
    Kienast J; Ostermann H; Stenzinger W; Kötter EM; van de Loo J
    Klin Wochenschr; 1989 Jul; 67(13):691-5. PubMed ID: 2502650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiphospholipid syndrome.
    Many A; Gitel S; Pauzner R
    Isr J Med Sci; 1989 Dec; 25(12):674-7. PubMed ID: 2515169
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.
    Asherson RA; Khamashta MA; Gil A; Vazquez JJ; Chan O; Baguley E; Hughes GR
    Am J Med; 1989 Apr; 86(4):391-9. PubMed ID: 2494884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The antiphospholipid antibody syndrome: a new clinical and therapeutic viewpoint in systemic lupus erythematosus].
    Bravo-Vargas G; Lavalle-Montalvo C
    Gac Med Mex; 1988; 124(1-2):39-42. PubMed ID: 3145236
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.
    Meyer O; Piette JC; Bourgeois P; Fallas P; Bletry O; Jungers P; Kahn MF; Godeau P; Ryckewaert A
    J Rheumatol; 1987 Jun; 14(3):502-6. PubMed ID: 3114485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus anticoagulant inhibition of in vitro prostacyclin release is associated with a thrombosis-prone subset of patients.
    Watson KV; Schorer AE
    Am J Med; 1991 Jan; 90(1):47-53. PubMed ID: 1898838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.